Study on the protective effect of the mixture of Shengmai powder and Danshen decoction on the myocardium of diabetic cardiomyopathy in the rat model

Chinese Journal of Integrative Medicine

Volumn 17, Issue 2, 2011, Pages 116-125

  Ni, Qing ^a,b   Wang, Jie ^a,b   Li, En Qing ^c   Zhao, An Bin ^c   Yu, Bin ^c   Wang, Min ^c   Huang, Chun Rong ^c  

^a Guang'anmen Hospital   (China)

^b INSTITUTE OF CHINESE MATERIA MEDICA   (China)

^c MEDICAL COLLEGE OF JINAN UNIVERSITY   (China)

Author keywords

Apoptosis; Chymase; Collagen fiber; Diabetic cardiomyopathy; Mixture of Shengmai powder and Danshen decoction; Thrombospodin 1; Tribbles homolog 3; Tumor growth factor 1

Indexed keywords

CHINESE DRUG; CHYMASE; COLLAGEN; SALVIA MILTIORRHIZA EXTRACT; SHENGMAI; STREPTOZOCIN; THROMBOSPONDIN 1; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; DIABETIC CARDIOMYOPATHY; DRUG EFFICACY; ELECTROCARDIOGRAPHY; HEART LEFT VENTRICLE; HEART MUSCLE; HEART MUSCLE CELL; HEART MUSCLE INJURY; HEART PROTECTION; IMMUNOHISTOCHEMISTRY; INSULIN RESISTANCE; LIPID DIET; NONHUMAN; POWDER; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; STREPTOZOCIN DIABETES;

ANIMALS; CYTOPROTECTION; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC CARDIOMYOPATHIES; DISEASE MODELS, ANIMAL; DRUG COMBINATIONS; DRUG EVALUATION, PRECLINICAL; DRUGS, CHINESE HERBAL; HEART; MALE; MYOCARDIUM; RATS; RATS, SPRAGUE-DAWLEY; STREPTOZOCIN;

EID: 79952555514     PISSN: 16720415     EISSN: 19930402     Source Type: Journal    
DOI: 10.1007/s11655-011-0639-9     Document Type: Article

References (29)

1. Rubler S, Dlugash J, Yuceoglu YZ, Kumral T, Branwood AW, Grishman A. New type of cardiomyopathy associated with diabetic glomerulosclerosis. Am J Cardiol 1972;30:595-602.
2. Hamby RI, Zoneraich S, Sherman L. Diabetic cardiomyopathy. JAMA 1974;229:1749-1754.
3. Poirier P, Bogaty P, Garneau C, Marois L, Dumesnil JG. Diastolic dysfunction in normotensive men with well-controlled type 2 diabetes: importance of maneuvers in echocardiographic screening for preclinical diabetic cardiomyopathy. Diabetes Care 2001;24:5-10. (Pubitemid 32104211)
4. Schannwell CM, Schneppenheim M, Perings S, Plehn G, Strauer BE. Left ventricular diastolic dysfunction as an early manifestation of diabetic cardiomypathy. Cardiology 2002;98:33-30.
5. Mizushige K, Yao L, Noma T, Kiyomoto H, Yu Y, Hosomi N, et al. Alteration in left ventricular diastolic filling and accumulation of myocardial collagen at insulin-resistant prediabetic stage of a type II diabetic rat model. Circulation 2000;101:899-907. (Pubitemid 30117886)
6. Asbun J, Villarreal FJ. The pathogenesis of myocardial fibrosis in the setting of diabetic cardiomyopathy. J Am Coll Cardiol 2006;47:693-700. (Pubitemid 43243087)
7. Cai L, Wang Y, Zhou G, Chen T, Song Y, Li X, et al. Attenuation by metallothionein of early cardiac cell death via suppression of mitochondrial oxidative stress results in a prevention of diabetic cardiomyopathy. Cardiology 2006;48:1688-1697. (Pubitemid 44528172)
8. Martin J, Kelly DJ, Mifsud SA, Zhang Y, Cox AJ, See F, et al. Tranilast attenuates cardiac matrix deposition in experimental diabetes: role of transforming growth factor-beta. Cardiovasc Res 2005;65:694-701. (Pubitemid 40138990)
9. Sowers JR, Epstein M, Frohlich ED. Diabetes, hypertension, and cardiovascular: an update. Hypertension 2001;37:1053-1059.
10. Ni Q, Jiang ZS, Gao QJ, Lin L, Li P, Yi DH, et al. The prescription rules of type 2 diabetes mellitus with coronary heart disease by the structural case data collection system. Chin J Integr Med Cardio-/Cerebrovasc Dis (Chin) 2008;6:7-8.
11. Deng CQ, Xiong MQ. Pathogenesis of diabetic cardiomyopathy and progress of traditional Chinese medicine in its prevention and treatment. J Guangzhou Univ Tradit Chin Med (Chin) 2001;18:181-184.
12. Morishima Y, Nomura A, Uchida Y, Noguchi Y, Sakamoto T, Ishii Y, et al. Triggering the induction of myofibroblast and fibrogenesis by airway epithelial shedding. Am J Respir Cell Mol Biol 2001;24:1-11. (Pubitemid 32097502)
13. Wang WM, Yao J, Shi R. Effect of transforming growth factor β1 on the expression of plasminogen activator inhibitor type 1 in human renal interstitial fibroblasts. Chin J Nephrol (Chin) 2000;16:50-51.
14. Bornstein P. Thrombospondins as matricellular modulators of cell function. J Clin Invest 2001;107:929-934. (Pubitemid 32323400)
15. Lawler J. The functions of thrombospondin-1 and-2. Curr Opin Cell Biol 2000;12:634-640.
16. Chen H, Herndon ME, Lawler J. The cell biology of thrombospondin-1. Matrix Biol 2000;19:597-614.
17. Kensuke S, Yukio S, Hisako M, Ken-ichiro H, Takashi M, Minoru U. Thrombospondin-1 promotes fibroblast-mediated collagen gel contraction caused by activation of latent transforming growth factor β-1. J Dermatol Sci 2003;31:99-109.
18. Kiss-Toth E, Bagstaff SM, Sung HY, Jozsa V, Dempsey C, Caunt JC, et al. Human tribbles, a protein family controlling mitogen-activated protein kinase cascades. J Biol Chem 2004;279:42703-42708. (Pubitemid 39372156)
19. Sung HY, Francis SE, Crossman DC, Kiss-Toth E. Regulation of expression and signaling modulator function of mammalian tribbles is cell-type specific. Immunol Lett 2006;10:171-177. (Pubitemid 43330724)
20. Monika S, Miroslav B, Jan N, Tanya R. Mitogen-activated protein kinases in the acute diabetic myocardium. Mol Cell Biochem 2003;249:59-65.
21. Saka M, Obata K, Ichihara S, Cheng XW, Kimata H, Noda A, et al. Attenuation of ventricular hypertrophy and fibrosis in rats by pitavastatin: potential role of the RhoA-extracellular signal-regulated kinase-serum response factor signalling pathway. Clin Exp Pharmacol Physiol 2006;33:1164-1171. (Pubitemid 44923903)
22. Cong L, Yu MH, Ii YM. Chymase and diabetic cardiomyopathy. Foreign Med Sci: Endocrinol Section (Chin) 2004;24 (Suppl):33-35.
23. Zhao XY, Zhao LY, Zheng QS, He YP, Lu XL. Chymase on cardiac fibroblast proliferation and collagen synthesis. Heart J (Chin) 2008;20:268-272.
24. Liao ZY, Jiang JL, Liu H. Effects of traditional Shengmai San on serum lipid and blood rheology & oxygen free radical of hyperlipidemia model rats. Liaoning J Tradit Chin Med (Chin) 2007;34:1478-1479.
25. Xie ZC, Qian ZK, Liu CW. Study on Ginseng in resisting lipid peroxidation injury in experimental diabetic rats. Chin J Integr Tradit West Med (Chin) 1993;13:290-299.
26. Chen QL, Ma LJ, Yang WB, Huang C. Effect of Yiqi Yangyin Huoxue Recipe against diabetic extremital gangrene in rats. Shandong Med J (Chin) 2005;45:12-14.
27. Dai Y, Chen LG, Hu XQ, Zhang C. The effects of Yiqi Huoxue Compound on myocardial fibrosis in spontaneously hypertensive rats. Lishizhen Med Mater Res (Chin) 2006;17:1134-1135.
28. Liao J, Huang CD, Ge JW, Yu R, Deng YH. Effect of Danshen Yin on experimental myocardial ischemia in rats. J Hunan Coll Tradit Chin Med (Chin) 2006;26(3):6-8.
29. Li WJ, Gu JX, Chen HL. Effects of Danshen on nonenzymatic binding of glucose and protein in vitro. J Shanghai Med Univ (Acta Acad Shanghai, Chin) 1998;25:131-135.